Servier Beats NHS' £220M Drug IP Suit At Top UK Court
Britain's highest court ruled on Friday that the government cannot seek £220 million ($300 million) from Servier Laboratories for allegedly making misrepresentations to Europe's intellectual property office and England's courts that...To view the full article, register now.
Already a subscriber? Click here to view full article